FFA
CRVS icon

Farther Finance Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Farther Finance Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.36K Buy
426
+387
+992% +$5.37K ﹤0.01% 4661
2026
Q1 		$563 Sell
39
-284
-88% -$4.53K ﹤0.01% 5241
2025
Q4 		$2.49K Buy
+323
New +$2.55K ﹤0.01% 4603

Other funds holding CRVS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.57B AUM 35.56% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Farther Finance Advisors's CRVS Position: Q2 2026 in Review

Farther Finance Advisors increased its Corvus Pharmaceuticals (CRVS) stake by 992% in Q2 2026, buying an estimated $5.37K and bringing the position to 426 shares worth $6.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4661.

Farther Finance Advisors first reported a position in CRVS in Q4 2025 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Farther Finance Advisors held 426 shares of Corvus Pharmaceuticals worth $6.36K as of Q2 2026.
  • Farther Finance Advisors bought 387 Corvus Pharmaceuticals shares in Q2 2026, an estimated $5.37K.
  • Corvus Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4661 holding.
  • Farther Finance Advisors first reported a position in Corvus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 24 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.